Hospital
Conway Hospital, INC.
Conway Hospital, INC. was paid $20.14M by Medicaid between Jan 2018 and Dec 2024, across 285 billing codes. Its largest line is 99283, emergency room visit (moderate) — 7.8% of everything it billed.
33Billing provider infoCONWAY HOSPITAL, INC.
CONWAY, SC 29526
CONWAY, SC 29526
33aNPI1134172000assigned 05/19/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$20.14M
24GClaims945,000
24DCodes billed285
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in South Carolina
Rank by total paid#18 of 115
Median peer was paid$2.47M
This provider vs. median8.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official ARTIOLI, MARY ELLEN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 159,578 | $2.56M | |
| 2019 | 151,475 | $2.40M | |
| 2020 | 115,920 | $2.36M | |
| 2021 | 134,824 | $3.05M | |
| 2022 | 157,365 | $3.98M | |
| 2023 | 124,545 | $3.36M | |
| 2024incomplete | 101,293 | $2.44M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 7.8% | 50,371 | 45,664 | $1.57M |
| 87428 | 7.4% | 17,162 | 15,979 | $1.50M | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 6.9% | 29,595 | 6,945 | $1.39M |
| 80053 | Comprehensive metabolic panel | 6.4% | 35,060 | 28,462 | $1.28M |
| A9585 | Injection, gadobutrol, 0.1 ml | 5.7% | 1,334 | 1,257 | $1.15M |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 5.6% | 8,569 | 7,525 | $1.12M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.7% | 10,582 | 9,798 | $940K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 2.9% | 2,171 | 998 | $584K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 2.4% | 1,648 | 1,522 | $474K |
| 81025 | 2.3% | 17,286 | 15,986 | $468K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.2% | 11,798 | 8,482 | $446K |
| 87070 | 2.0% | 8,713 | 7,875 | $405K |
273 more codes
| 99284 | Emergency room visit (serious) | 1.9% | 32,925 | $380K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.7% | 13,310 | $344K |
| 87400 | 1.6% | 11,337 | $314K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.6% | 13,237 | $313K |
| 76376 | 1.5% | 4,135 | $307K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.5% | 7,159 | $297K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.4% | 3,460 | $282K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.2% | 16,935 | $249K |
| 84702 | 1.1% | 2,916 | $226K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.1% | 2,631 | $219K |
| 71250 | <1% | 1,196 | $198K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 7,938 | $196K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 4,807 | $180K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 7,987 | $167K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,259 | $165K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 10,715 | $164K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 417 | $158K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 7,302 | $152K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 12,266 | $142K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 3,699 | $142K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 7,882 | $140K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 45,207 | $138K |
| 81001 | <1% | 25,482 | $124K | |
| 72141 | <1% | 235 | $122K | |
| 73630 | <1% | 2,533 | $120K | |
| 93971 | <1% | 1,261 | $114K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 61,177 | $112K |
| 99285 | Emergency room visit (most serious) | <1% | 17,943 | $110K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 12,036 | $109K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 1,570 | $105K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 4,156 | $105K |
| 88304 | <1% | 1,690 | $104K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 2,208 | $101K |
| 71045 | Radiologic examination, chest; single view | <1% | 15,165 | $100K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 16,080 | $89K |
| 93356 | <1% | 597 | $84K | |
| 73564 | <1% | 2,655 | $83K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 934 | $83K |
| 73130 | <1% | 1,527 | $80K | |
| 73610 | <1% | 2,030 | $71K | |
| 76536 | <1% | 862 | $69K | |
| 96376 | <1% | 5,692 | $65K | |
| 76770 | <1% | 857 | $65K | |
| 81003 | <1% | 8,319 | $65K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 2,598 | $63K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 3,255 | $62K |
| 74018 | <1% | 1,941 | $59K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,995 | $56K |
| 87186 | <1% | 2,868 | $55K | |
| 87430 | <1% | 6,924 | $54K | |
| 0240U | <1% | 727 | $51K | |
| 59025 | Fetal non-stress test | <1% | 1,379 | $50K |
| 72100 | <1% | 2,181 | $48K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 4,265 | $46K |
| 77066 | Tomosynthesis, mammo | <1% | 259 | $44K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 341 | $43K |
| 82247 | <1% | 2,915 | $40K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 279 | $40K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 6,270 | $39K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 3,103 | $39K |
| 76641 | <1% | 787 | $37K | |
| 73030 | <1% | 1,709 | $37K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 3,315 | $37K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 234 | $36K |
| G0378 | Hospital observation service, per hour | <1% | 9,994 | $36K |
| 85027 | <1% | 6,865 | $35K | |
| 82728 | <1% | 1,539 | $34K | |
| 86900 | <1% | 5,234 | $30K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,074 | $29K |
| 73502 | <1% | 979 | $28K | |
| 85018 | <1% | 1,160 | $26K | |
| 97161 | <1% | 3,673 | $25K | |
| 73110 | <1% | 1,009 | $25K | |
| 93017 | <1% | 1,767 | $25K | |
| 76830 | Ultrasound, transvaginal | <1% | 491 | $24K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 17,173 | $24K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 5,703 | $23K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 5,824 | $20K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,725 | $18K |
| 87077 | <1% | 3,147 | $17K | |
| 76642 | <1% | 475 | $17K | |
| 87420 | <1% | 4,626 | $15K | |
| 97032 | <1% | 7,642 | $15K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 2,526 | $15K |
| J2704 | Injection, propofol, 10 mg | <1% | 10,581 | $15K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 261 | $14K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 307 | $14K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,967 | $14K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 51 | $13K |
| 85007 | <1% | 3,513 | $13K | |
| 87507 | <1% | 50 | $13K | |
| 70486 | <1% | 318 | $11K | |
| 83735 | <1% | 8,303 | $11K | |
| 73080 | <1% | 397 | $11K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 101 | $11K |
| 84484 | <1% | 10,583 | $11K | |
| 93225 | <1% | 31 | $10K | |
| 73140 | <1% | 169 | $10K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 4,843 | $10K |
| 82565 | <1% | 408 | $10K | |
| 87040 | <1% | 2,551 | $10K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 40 | $9K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 14 | $9K |
| 85610 | <1% | 7,928 | $9K | |
| 76801 | <1% | 1,522 | $9K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 184 | $8K |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 1,374 | $7K |
| 73221 | <1% | 12 | $7K | |
| 10060 | <1% | 243 | $7K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 2,499 | $6K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 90 | $6K |
| 95813 | <1% | 42 | $6K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 4,284 | $6K |
| 72040 | <1% | 162 | $6K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 1,040 | $5K |
| 87147 | <1% | 472 | $5K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 2,571 | $5K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,295 | $5K |
| 85730 | <1% | 3,849 | $5K | |
| 96367 | <1% | 683 | $5K | |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | <1% | 510 | $4K |
| 83690 | <1% | 11,191 | $4K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 11,917 | $4K |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 921 | $4K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 1,455 | $4K |
| 84112 | <1% | 32 | $4K | |
| 87045 | <1% | 111 | $4K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 3,479 | $4K |
| 83550 | <1% | 1,650 | $4K | |
| 82731 | <1% | 32 | $4K | |
| 83540 | <1% | 1,740 | $4K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,119 | $3K |
| 87210 | <1% | 2,656 | $3K | |
| 83880 | <1% | 2,332 | $3K | |
| 72070 | <1% | 76 | $3K | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 595 | $3K |
| 82272 | <1% | 553 | $3K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,563 | $3K |
| 77065 | Tomosynthesis, mammo | <1% | 31 | $3K |
| 83605 | <1% | 1,688 | $3K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 1,290 | $2K |
| 80061 | Lipid panel | <1% | 2,149 | $2K |
| 94060 | <1% | 16 | $2K | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 1,398 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 8,986 | $2K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 1,102 | $2K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 8,632 | $2K |
| 80076 | <1% | 181 | $2K | |
| 86140 | <1% | 1,459 | $2K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 102 | $2K |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 2,161 | $2K |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 2,290 | $2K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 11,002 | $2K |
| 85379 | <1% | 999 | $2K | |
| 97022 | <1% | 58 | $1K | |
| 82550 | <1% | 2,425 | $1K | |
| 86592 | <1% | 795 | $1K | |
| 82784 | <1% | 28 | $1K | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 738 | $1K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 398 | $1K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 204 | $1K |
| 70491 | <1% | 42 | $980.44 | |
| 12001 | <1% | 205 | $940.85 | |
| 82553 | <1% | 1,784 | $927.92 | |
| 80329 | <1% | 2,053 | $811.28 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 310 | $765.31 |
| 93970 | <1% | 13 | $760.29 | |
| 82570 | <1% | 497 | $736.32 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 908 | $721.42 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 5,883 | $714.06 |
| J0280 | Injection, aminophyllin, up to 250 mg | <1% | 243 | $692.38 |
| 73090 | <1% | 29 | $665.42 | |
| 76870 | <1% | 15 | $662.83 | |
| 82607 | <1% | 894 | $639.22 | |
| 97597 | <1% | 52 | $626.43 | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 13 | $597.08 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,141 | $576.50 |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 623 | $525.14 |
| 80164 | <1% | 12 | $491.21 | |
| 76000 | <1% | 195 | $480.26 | |
| 74019 | <1% | 26 | $371.40 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 717 | $346.93 |
| 90715 | <1% | 1,142 | $345.52 | |
| 97162 | <1% | 131 | $341.82 | |
| 85651 | <1% | 1,659 | $338.41 | |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | <1% | 31 | $315.91 |
| 97116 | <1% | 995 | $236.94 | |
| 73590 | <1% | 47 | $211.36 | |
| 84165 | <1% | 430 | $120.59 | |
| 84550 | <1% | 199 | $119.39 | |
| 86901 | <1% | 5,232 | $107.17 | |
| 94664 | <1% | 316 | $105.13 | |
| 87205 | <1% | 1,485 | $103.68 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 79 | $100.08 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 169 | $96.68 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 2,390 | $87.98 |
| 84439 | <1% | 1,436 | $83.33 | |
| 97165 | <1% | 15 | $65.02 | |
| 84030 | <1% | 14 | $63.81 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 522 | $50.00 |
| 85045 | <1% | 173 | $44.61 | |
| 82248 | <1% | 2,663 | $32.38 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 677 | $25.23 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 13 | $23.66 |
| 84132 | <1% | 125 | $22.08 | |
| 90686 | <1% | 92 | $19.03 | |
| 86308 | <1% | 40 | $6.45 | |
| 86850 | <1% | 1,668 | $5.55 | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 718 | $1.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 2,769 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 0% | 420 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 984 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 0% | 403 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 170 | $0.00 |
| 83615 | 0% | 422 | $0.00 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 158 | $0.00 |
| D7140 | Extraction, erupted tooth or exposed root | 0% | 189 | $0.00 |
| D1208 | Topical application of fluoride, excluding varnish | 0% | 185 | $0.00 |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 0% | 20 | $0.00 |
| C1889 | Implantable/insertable device, not otherwise classified | 0% | 308 | $0.00 |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 42 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 40 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 141 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 120 | $0.00 |
| 95851 | 0% | 13 | $0.00 | |
| 88307 | 0% | 40 | $0.00 | |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | 0% | 139 | $0.00 |
| C9290 | Injection, bupivacaine liposome, 1 mg | 0% | 43 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 30 | $0.00 |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 0% | 77 | $0.00 |
| 51798 | 0% | 18 | $0.00 | |
| 82746 | 0% | 67 | $0.00 | |
| 82150 | 0% | 24 | $0.00 | |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 0% | 39 | $0.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 262 | $0.00 |
| 12002 | 0% | 12 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 1,114 | $0.00 |
| C1769 | Guide wire | 0% | 13 | $0.00 |
| J0706 | Injection, caffeine citrate, 5 mg | 0% | 20 | $0.00 |
| D2330 | 0% | 22 | $0.00 | |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 15 | $0.00 |
| 83050 | 0% | 13 | $0.00 | |
| 87449 | 0% | 12 | $0.00 | |
| 85014 | 0% | 90 | $0.00 | |
| J1953 | Injection, levetiracetam, 10 mg | 0% | 16 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 166 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 188 | $0.00 |
| 77062 | 0% | 146 | $0.00 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 769 | $0.00 |
| 84481 | 0% | 14 | $0.00 | |
| D2930 | Prefabricated stainless steel crown - primary tooth | 0% | 583 | $0.00 |
| J3105 | Injection, terbutaline sulfate, up to 1 mg | 0% | 46 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 99 | $0.00 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 0% | 669 | $0.00 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 0% | 226 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 181 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 153 | $0.00 |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 0% | 42 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 57 | $0.00 |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 0% | 38 | $0.00 |
| 87324 | 0% | 12 | $0.00 | |
| 84100 | 0% | 51 | $0.00 | |
| 47562 | 0% | 12 | $0.00 | |
| 99218 | 0% | 36 | $0.00 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 13 | $0.00 |
| 93226 | 0% | 13 | $0.00 | |
| 94729 | 0% | 13 | $0.00 | |
| 99219 | 0% | 43 | $0.00 | |
| 86038 | 0% | 14 | $0.00 | |
| D2934 | 0% | 18 | $0.00 | |
| 82375 | 0% | 15 | $0.00 | |
| 82805 | 0% | 14 | $0.00 | |
| 94726 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialARTIOLI, MARY ELLEN (CREDENTIALING SPECIALIST)
| Provider | Location | Paid |
|---|---|---|
| Conway Hospital INC | Myrtle Beach, SC | $4.94M |
| Conway Hospital, INC. | Conway, SC | $2.90M |
| Conway Hospital, INC. | Conway, SC | $2.17M |
| Conway Hospital, INC. | Myrtle Beach, SC | $1.23M |
| Conway Hospital, INC. | Myrtle Beach, SC | $574K |
| Conway Hospital, INC. | Conway, SC | $529K |
| Conway Hospital, INC | Conway, SC | $481K |
| Conway Hospital, INC. | Conway, SC | $451K |
| Conway Hospital Community Services | Aynor, SC | $412K |
| Conway Hospital, INC. | Conway, SC | $382K |
| Conway Hospital, INC. | Myrtle Beach, SC | $323K |
| Conway Hospital, INC. | Conway, SC | $217K |
| Conway Hospital Community Services | Aynor, SC | $199K |
| Conway Hospital, INC. | Conway, SC | $192K |
| Conway Hospital INC | Conway, SC | $176K |
| Conway Hospital, INC. | Conway, SC | $168K |
| Conway Hospital, INC | Conway, SC | $152K |
| Conway Hospital, INC. | Conway, SC | $141K |
| Conway Hospital, INC. | Conway, SC | $133K |
| Conway Hospital, INC. | Conway, SC | $123K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.